Olema Pharmaceuticals, Inc. OLMA Operating lease liabilities
Operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s operating lease liabilities?
- Olema Pharmaceuticals, Inc. (OLMA) reported operating lease liabilities of -$313K in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s operating lease liabilities changed year-over-year?
- Olema Pharmaceuticals, Inc.'s operating lease liabilities decreased by 1.3% year-over-year, from -$309K to -$313K.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s operating lease liabilities?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s operating lease liabilities has grown at a 5.9% compound annual growth rate (CAGR), from -$988K to -$1.24M.